Delivery Order SPE2DB24D1007-SPE2DB25FCCSC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,594.64 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price delivery order under a non-set-aside competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $7,540.20 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack units). This competitive award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,329.63 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive, non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and operates under firm fixed price terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a $2,665.50 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency has awarded a $1,477.10 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,996.40 for epinephrine 0.3 mg auto-injector (2-pack) on July 31, 2025, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a critical pharmaceutical supply need within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,082.90. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCSCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,178.39 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This competitively awarded, firm fixed-price contract was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive global portfolio of pharmaceutical products and medical supplies to military healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive medical procurement requirements across a wide range of therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/1/25 |